India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Abhishek Sharma created history during a match against Afghanistan on 17 September 2026, where he…
N Chandrasekaran has been given the position of chairman of Tata Sons again for a…
Computer scientist and engineer Sethuraman Panchanathan has been conferred the 2026 Arthur M. Bueche Award…
Honorable Prime Minister of India Narendra Modi inaugurated SEMICON India 2026, the fifth edition of…
The Global Gender Gap Index 2026 by the World Economic Forum (WEF) ranks India at…
India has been placed in the “severely restricted” category in the 2026 Free to Think…